Dianthus Therapeutics Insider Sold Shares Worth $738,844, According to a Recent SEC Filing

Ryan Savitz, Executive Vice President, Chief Financial Officer & Chief Business Officer, on April 09, 2026, sold 8,224 shares in Dianthus Therapeutics (DNTH) for $738,844.SEC Filing:https://www.sec.gov/Archives/edgar/data/1690585/000199232426000006/xslF345X05/ownership.xml